Health Trials

About this trial

The goal of this clinical trial is to investigate the effectiveness of yoga for patients with chronic low back pain and high risk of poor prognosis. The main question it aims to answer is:

\- In patients with back pain and high risk of poor prognosis, what is the effectiveness of yoga plus education on reducing pain and disability compared to a control group receiving education alone?

A total of 110 patients with chronic low back pain and classified as high risk of poor prognosis according to the Orebro Musculoskeletal Pain Screening Questionnaire (i.e. score ≥ 50 points out of 100) will be recruited for this study. Participants will be randomized into two groups: yoga and control. The yoga group will receive a 3-month course of yoga program consisting of two sessions per week and 3 educational classes. The control group will receive 3 educational classes over a 12-week period. Outcome measures will be assessed at baseline, at post-intervention (i.e. 3-months post randomization) and at 6-month follow up (i.e. 6-months post randomization).

Eligibility criteria

Qualifiers

report chronic nonspecific LBP, defined as pain and discomfort localized below the costal margin and above the inferior gluteal folds, with or without leg pain and of at least 3 months' duration.

score ≥ 50 points (out of 100) in the Orebro Musculoskeletal Pain Questionnaire.

have an average back pain intensity of 3 points or more on a 0-10 numerical pain rating scale.

Disqualifiers

serious spine pathology (e.g. tumors, fractures, and inflammatory diseases).

nerve root compromise (i.e. at least 2 of the following signs: weakness, reflex change, or sensation loss associated with the same spinal nerve).

previos spinal surgery.

pregnancy or having given birth within the previous 3 months.

Trial design

Treatments tested in this trial

  • Control
  • Yoga

Treatment groups

110 Participants
are divided into 2 treatment groups

Locations

1
IPSEMG - Instituto de Previdência dos Servidores do Estado de Minas Gerais30130-110, Belo HorizonteMinas Gerais, Brazil

Sponsors and collaborators

Federal University of Minas Gerais

Lead sponsor

Source ClinicalTrials.gov